Heart disease is the leading cause of death in the United States in both men and women. It accounted for more than
652 thousand deaths in the United States in 2005, which was about 27% of total deaths that year. By far the largest sub-category of heart disease deaths is
coronary heart disease, which is an obstruction of the arteries that supply the heart muscle with blood. When the obstruction of the coronary arteries is great enough, the amount of oxygen-carrying blood reaching the heart muscle (myocardium) is reduced, which can result in the death of heart muscle, which is known as a myocardial infarction – or a “heart attack” in common language. This situation usually requires aggressive treatment measures, consisting either of direct relief of the obstructed coronary artery or arteries (called percutaneous coronary intervention) or coronary artery bypass surgery, in addition to drug treatment.
It has long been known that men, on average, are Gender differences in Rx
more aggressively treated for coronary heart disease (CHD) than are women. And it has also long been known that, although CHD is more common in men, it is more highly fatal in women. That has raised the question of
WHY, if it is more fatal in women, is it treated more aggressively in men.
There has been no consensus on the answer to that question. One theory has been that the less aggressive treatment in women is do to the fact that women with CHD tend to be older and have more serious co-existing diseases than do men. Their older age and more serious co-existing diseases could and often do pose a barrier to aggressive treatment of their CHD. However, most studies that have analyzed this issue have found that treatment of men for CHD is, on average, still more aggressive than the treatment of women even after statistically controlling for age and co-existing disease. Those studies therefore showed that age and co-existing disease cannot fully explain the more aggressive treatment of CHD in men than in women.
The two other most prominent theories to explain the less aggressive treatment of CHD in women are: 1) Gender bias (of unknown reason) against women – meaning that doctors tend to give women insufficient treatment for CHD; or 2) More severe disease of the coronary arteries in men than in women – which could justify more aggressive treatment in men than in women.
In this post I’ll discuss a research study that I conducted at the Food and Drug Administration (FDA) to explore the second theory noted above – that men are treated for CHD more aggressively than women because they have more severe disease. This study was funded by the
Office of Women’s Health at the FDA, whose main mission is to “Protect and advance the health of women through policy, science, and outreach”. It was the first large study that analyzed gender differences in treatment of CHD by comparing groups of men and women who had similar degrees of severity of coronary artery disease. I will present the results of this study at FDA conferences on September 25th and November 10th, and they will be published in the journal
Clinical Cardiology.
FDA STUDY TO ASSESS GENDER DIFFERENCES IN THE TREATMENT OF MYOCARDIAL INFARCTIONMethodsThe data for this study came from a registry (the acronym is
CRUSADE) of coronary heart disease patients maintained at Duke University Medical Center. In collaboration with researchers from Duke University, we analyzed the records of 32,888 patients who were diagnosed with myocardial infarction and treated at 522 different clinical sites throughout the United States from 2001 through 2006.
Of the 32,888 patients who were included in our study, 18,448 received diagnostic cardiac catheterization. That is a procedure whereby a radio-opaque dye is injected into the coronary artery system, followed by X-rays to assess the degree of obstruction of the coronary arteries.
We divided the study population into four different categories of CHD severity: no significant obstruction; one coronary artery obstructed; two coronary arteries obstructed; and, three coronary arteries obstructed. We also divided the population into four different age groups. We then compared the percentage of men vs. women who were treated with either coronary artery bypass surgery or percutaneous coronary intervention within each of the groupings by age and number of obstructed coronary arteries. We did that so that we could be confident that all of our gender comparisons involved women and men with similar degrees of coronary artery obstruction and age.
We also made similar gender comparisons with regard to drug treatment for five different drugs that are commonly used to treat acute myocardial infarction.
ResultsIn 7 of the 16 age-CHD severity groups, men were characterized by a statistically higher frequency of coronary artery intervention than were women. There were no age-CHD groups in which women were characterized by a statistically higher frequency of coronary artery intervention than men.
As an example, consider men and women with obstruction of one coronary artery: In the less than 65-year age group, 86% of men were treated with coronary intervention, compared to 77% of women; in the 65-74-year age group, 82% of men were treated, compared to 74% of women; in the 75-84-year age group, 79% of men were treated, compared to 73% of women, and; in the 85-year and above age group, 73% of men were treated, compared to 70% of women.
Similar findings (i.e. greater frequency of treatment in men than women) were found for four of the five drug treatment categories that we analyzed.
The meaning of these findingsThese findings go a long way towards showing that the reason for more aggressive treatment of CHD in men than in women is not due to a greater severity of CHD in men than in women, since we compared men and women with similar numbers of obstructed coronary arteries against each other. This study doesn’t
completely rule out a greater severity of CHD in men than in women as the explanation for their more aggressive treatment. It is possible, for example, that men with a given number of obstructed coronary arteries had
more obstruction of their arteries than women with the same
number of obstructed coronary arteries (That data was not collected in this study). But then, if more severely diseased coronary arteries explained the greater frequency of coronary artery intervention in men compared to women, then what would explain the more frequent use of drug treatment in men than in women? In summary, these results go a long way towards ruling
out greater severity of coronary artery disease in men as an explanation for their receiving more aggressive treatment than women.
GENDER-BASED TREATMENT BIAS?In the conclusion to our soon to be published journal article we address the possibility of gender-based treatment bias, by asking the key question:
If the lower rates of coronary intervention and medical treatment in women can be explained neither by differences in diagnostic findings nor age, that raises the possibility of a gender-based treatment bias on the part of physicians, which leads them to consider CHD less seriously in women than in men... That is a very serious matter, given that the prognosis of CHD is generally worse in women than in men and that their worse prognosis is possibly explained at least in part by less aggressive treatment in women.
There are other possible explanations for the gender differences in treatment. For example it is possible that physicians treat women less aggressively for this disease because women
prefer to be treated less aggressively. I’m not saying that’s likely, but it does seem possible, and as far as I know that possibility has never been extensively analyzed. And, there could be other explanations that most of us haven’t thought of.
WHY would physicians have a treatment bias against women?One explanation that might explain a physician treatment bias against women with respect to CHD is the simple fact that CHD is more common in men than in women. But based on the results of this study, that explanation doesn’t seem very likely, since women still receive less frequent treatment of CHD even when they’ve been diagnosed with it by angiography.
After giving the matter much thought, it seems reasonably possible to me that the explanation involves socio-economic status and insurance coverage. Women on average make less money than men, and they’re likely to have worse insurance coverage. A
study by Charlotte Muller showed that:
Women use more family and personal funds and rely more on Medicaid; men have more and better coverage by private insurance and are more likely to be covered by Veterans Administration programs and by Workers’ Compensation. Women, paying more expenses out of pocket than men, are more likely to have unmet health care needs.
A relative lack of insurance coverage is undoubtedly translated into less medical care. With regard to Muller’s studies:
It is interesting to note that when men and women are given routine examinations for the same conditions, men tend to receive more tests; perhaps this indicates that men’s complaints are often taken more seriously than women’s.
Yes, it could indicate that men’s complaints are often taken more seriously than women’s. But it could also be explained by less insurance coverage – or by a combination of these two reasons.
A much smaller study that I participated on using funds from the Office of Women’s Health at the FDA suggested that black patients are less aggressively treated for CHD than white patients. It is possible that a relative lack of health insurance coverage partly explains the differences in CHD treatment by both gender
and race.
Our next step, if I can get permission to continue with this research, will be to examine how socioeconomic status in general, and different kinds of insurance coverage in particular affect differences in CHD treatment by race and by gender.